Bioserenity

Bioserenity

Bioserenity

French healthcare company


BioSerenity is a medtech company created in 2014 that develops ambulatory medical devices to help diagnose and monitor patients with chronic diseases[3] such as epilepsy.[4] The medical devices are composed of medical sensors, smart clothing,[5] a smartphone app for Patient Reported Outcome, and a web platform to perform data analysis through Medical Artificial Intelligence[6][7] for detection of digital biomarkers.[8] The company initially focused on Neurology,[9] a domain in which it reported contributing to the diagnosis of 30 000 patients per year.[10] It now also operates in Sleep Disorders and Cardiology.[11] BioSerenity reported it provides pharmaceutical companies with solutions for companion diagnostics.[12]

Quick Facts Company type, Industry ...

Company history

BioSerenity was founded in 2014, by Pierre-Yves Frouin. The company was initially hosted at the ICM Institute (Institute du Cerveau et de la Moëlle épinière),[13][14] in Paris, France.

Fund Raising

  • June 8, 2015 : The company raises a $4 million seed round with Kurma Partners and IdInvest Partners[15]
  • September 20, 2017 : The company raises a $17 million series A round with LBO France, IdInvest Partners and BPI France[16]
  • June 18, 2019 : The company raises a $70 million series B round with Dassault Systèmes, IdInvest Partners, LBO France et BPI France[17]
  • November 13, 2023 : The company raises a 24M€ series C round with Jolt Capital[18]

Acquisitions

In 2019, BioSerenity announced the acquisition of the American Company SleepMed[19] and working with over 200 Hospitals.

In 2020, BioSerenity was one of the five French manufacturers (Savoy, BB Distrib, Celluloses de Brocéliande, Chargeurs) working on the production of sanitary equipment including FFP2 masks at request of the French government.[20]

In 2021, the Neuronaute would be used by approximately 30,000 patients per year.[21]

Awards

  • BioSerenity is one of the Disrupt 100[22]
  • BioSerenity joined the Next40[23]
  • BioSerenity was selected by Microsoft and AstraZeneca in their initiative AI Factory for Health[24]
  • BioSerenity accelerated at Stanford's University StartX program[25]

References

  1. Fouassier, David (2020). "Assessment of signal quality measured with a smart 12‐lead ECG acquisition T‐shirt". Annals of Noninvasive Electrocardiology. 25 (1). Wiley: e12682. doi:10.1111/anec.12682. PMC 7050501. PMID 31339208.(citing PMID 31339208)
  2. Cairns, Alyssa (February 2019). "Comparison of the macro and microstructure of sleep in a sample of sleep clinic hypersomnia cases". Neurobiology of Sleep and Circadian Rhythms. 6. Elsevier: 62–69. doi:10.1016/j.nbscr.2019.02.001. PMC 6586604. PMID 31236521.(citing PMID 31236521)
  3. "La HealthTech, la mine d'or méconnue de la French Tech". latribune.fr (in French). February 12, 2020. Retrieved September 10, 2021.
  4. "NHS could soon use smart outfit to diagnose epilepsy". www.newscientist.com. June 1, 2016. Retrieved September 10, 2021.
  5. "Textiles connectés, où quand les vêtements scrutent les mouvements". Le Temps (in French). January 29, 2016. Retrieved September 10, 2021.
  6. "BioSerenity : l'intelligence artificielle et la data au service du patient". Les Echos (in French). September 20, 2019. Retrieved September 10, 2021.
  7. "These Sensor-Studded Smart Clothes Just Might Save Your Life". www.wsj.com. September 7, 2021. Retrieved September 10, 2021.
  8. "BioSerenity". www.icm-institute.org/.
  9. "Un tee-shirt qui diagnostique l'épilepsie". Le Monde.fr. September 30, 2014.
  10. "BioSerenity, champion français de la e-santé, lève 15 millions d'Euros" (PDF). lyonbiopole.com/ (in French). September 20, 2017. Archived from the original (PDF) on June 16, 2021. Retrieved September 10, 2021.
  11. "Jolt Capital Fuels BioSerenity's MedTech Revolution with €24M Investment". technews180.com. November 14, 2023. Retrieved November 15, 2023.
  12. Loye, Deborah (September 23, 2019). "BioSerenity rachète l'américain SleepMed". Les Echos Executives (in French). Retrieved September 10, 2021.
  13. "Les usines de l'Hexagone en ordre de bataille pour les protections sanitaires". LEFIGARO (in French). July 28, 2020. Retrieved June 30, 2022.
  14. Ledoux, Aurélie (2009). "Vidéos en ligne : la preuve par l'image ?". Esprit. Mars/avril (3): 95. doi:10.3917/espri.0903.0095. ISSN 0014-0759.
  15. "BioSerenity". disrupt100.com. Archived from the original on February 27, 2020. Retrieved September 10, 2021.
  16. "BioSerenity". Next40.org (in French). Retrieved September 10, 2021.
  17. "Companies". www.startx.com.

Share this article:

This article uses material from the Wikipedia article Bioserenity, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.